Combating Whooping Cough

With pertussis outbreaks on the rise this year, a timely animal model study provides hope for an antibody treatment.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, SANOFI PASTEUROutbreaks of whooping cough, or pertussis, occurred in multiple locations worldwide this year at higher rates than in 2014. The Dutch health council recently recommended that pregnant women receive vaccinations in the last three months of their pregnancy—and researchers from Texas have developed antibodies to potentially treat the disease, reported yesterday (December 2) in Science Translational Medicine.

In Clark Country, Washington, local health officials have declared an end to a recent whooping cough outbreak. “Through November, Clark County health officials recorded 345 cases of whooping cough, compared with just 52 cases during the same period last year,” reported The Columbian, though the disease rates are on the decline.

Across the Pacific Ocean, whooping cough outbreaks are ramping up in Australia. “Western Sydney Local Health District has experienced a steady increase in pertussis (whooping cough) notifications since late 2014,” communicable diseases manager Shopna Bag told The Daily Telegraph. Last year, 400 cases of whooping cough were reported in western Sydney—but the area has seen more than 1,200 reports of the disease in 2015. In Europe, the Dutch health council recently recommended that pregnant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies